ULTRAGENYX PHARMACEUTICAL INC. Short-term Investments
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Short-term Investments of $568.03 million as of 2020-09-30, per its 10-Q filed 2020-10-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2020-10-27
- 2020-09-30: Short-term Investments $568.03M.
- 2020-06-30: Short-term Investments $477.78M.
- 2020-03-31: Short-term Investments $365.09M.
- 2019-12-31: Short-term Investments $321.65M.
| Period end | Short-term Investments |
|---|---|
| 2020-09-30 | $568.03M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $477.78M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $365.09M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $321.65M 10-Q · filed 2020-10-27 |
| 2019-09-30 | $404.48M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $486.95M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $445.60M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $346.27M 10-K · filed 2020-02-14 |
| 2018-09-30 | $420.14M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $436.28M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $314.62M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $134.00M 10-K · filed 2019-02-20 |
| 2017-09-30 | $310.66M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $308.90M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $265.69M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $219.03M 10-K · filed 2018-02-21 |
| 2016-09-30 | $254.15M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $336.73M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $341.09M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $343.43M 10-K · filed 2017-02-17 |
| 2015-09-30 | $281.70M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $273.68M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $164.53M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $163.16M 10-K · filed 2016-02-26 |
| 2014-09-30 | $147.81M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $135.82M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $109.95M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $45.95M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |